Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer.
暂无分享,去创建一个
T. Scheper | D. Bogdanos | C. Papandreou | C. Tsigalou | C. Liaskos | L. Sakkas | A. Gkoutzourelas | W. Meyer | J. Hajiioannou | E. Patrikiou | V. Papadopoulos | Athanasios Sarantziotis